http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211925-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3acccdaa337a590589a2e98bbab46da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34af67ecf815d013b8242035bbeb840f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f002aa44083ba553607d5bc928df7c3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f396f1abf2c1170f12348c7a071562c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f8c7b5d458457032c6f379fe9c0b4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b14a4b6b0eec3ec054220717cee086b
publicationDate 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021211925-A1
titleOfInvention Treatment methodology for the prevention and control of viral infections
abstract A treatment methodology for the prevention and control of viral infections by administering an anti-viral composition having organotrophic archaea microorganisms, a carrier substance and an activating liquid, characterized in that the archaea microorganisms, when present in human or animal, weaken or destroy a virus upon contact. The anti- viral composition is administered either intraorally or intranasally.
priorityDate 2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5459984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227246662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444493

Total number of triples: 34.